Astra Enters Obesity Drug Race With Chinese Biotech Deal

Japan’s Biggest Firms Set for $9.3 Billion Bonanza From Weak Yen

Merck Discontinues Developing Drug Candidates With Sichuan Kelun After Daiichi Sankyo Deal

Asia Stocks Set For Losses as US Volatility Rises: Markets Wrap

Daiichi Sankyo Leads Japan Pharma Stocks Higher on Cancer Drug

Astra Strikes $1 Billion Gene Therapy Deal With Pfizer

New AstraZeneca Cancer Drug Shows Potential in Key Study

AstraZeneca’s Japan Partner to Go Solo on Future Cancer Drugs